NCT01655862View on ClinicalTrials.gov

A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Torticollis
Interventions
BIOLOGICAL

OnabotulinumtoxinA

OnabotulinumtoxinA injections at doses and frequencies as determined by the physician in accordance with clinical practice.

Trial Locations (8)

J4V 2J2

Clinique Neuro-Rive Sud, Greenfield Park

H1T 2M4

Hôpital Maisonneuve-Rosemont, Montreal

H2L 4M1

Chum-Notre-Dame, Montreal

H4A 3L5

Queen Elizabeth Health Centre: Medical Specialist Clinic, Montreal

G1J 1Z4

CHU de Québec, Hôpital de l'Enfant-Jésus, Québec

G2K 0H1

Centre Medical Le Mesnil, Québec

G6W 8H1

Polyclinique Medicale des Ponts, Saint Romuald

J1H 5N4

CHU - Sherbrooke, Sherbrooke

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT01655862 - A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA | Biotech Hunter | Biotech Hunter